These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32971631)

  • 1.
    Narasimhan S; Joshi M; Parameswaran S; Rishi P; Khetan V; Ganesan S; Biswas J; Sundaram N; Sreenivasan J; Verma S; Krishnamurthy V; Subramanian K
    Indian J Ophthalmol; 2020 Oct; 68(10):2160-2165. PubMed ID: 32971631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.
    Miserocchi E; Ferreri AJM; Giuffrè C; Cangi MG; Francaviglia I; Calimeri T; Ponzoni M; Pecciarini L; Bandello FM; Modorati GM
    Retina; 2019 Apr; 39(4):679-684. PubMed ID: 30204732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
    Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
    Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
    [No Abstract]   [Full Text] [Related]  

  • 5. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
    Tan WJ; Wang MM; Castagnoli PR; Tang T; Chan ASY; Lim TS
    Ophthalmology; 2021 Jul; 128(7):1079-1090. PubMed ID: 33221324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment.
    Demirci H; Rao RC; Elner VM; Demirci FY; Axenov L; Betz B; Behdad A; Brown N
    Ophthalmol Retina; 2023 Feb; 7(2):189-195. PubMed ID: 35952929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial Detection of
    Choi S; Shin S; Lee ST; Lee J; Lee JS; Kim B; Lee CS
    Ocul Immunol Inflamm; 2021 Apr; 29(3):485-489. PubMed ID: 32965155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.
    Kwak JJ; Lee KS; Lee J; Kim YJ; Choi EY; Byeon SH; Chang WS; Kim YR; Kim JS; Shin S; Lee ST; Kim SS; Lee CS
    Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):27. PubMed ID: 37975847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection of the MYD88 L265P mutation for pre- and intra-operative diagnosis of primary central nervous system lymphoma.
    Yamaguchi J; Ohka F; Kitano Y; Maeda S; Motomura K; Aoki K; Takeuchi K; Nagata Y; Hattori H; Tsujiuchi T; Motomura A; Nishikawa T; Kibe Y; Shinjo K; Kondo Y; Saito R
    Cancer Sci; 2023 Jun; 114(6):2544-2551. PubMed ID: 36859777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
    Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
    Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA.
    Raja H; Salomão DR; Viswanatha DS; Pulido JS
    Retina; 2016 Mar; 36(3):624-8. PubMed ID: 26900675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
    Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
    Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
    [No Abstract]   [Full Text] [Related]  

  • 14. Posterior Uveitis in Ocular-Involving Chronic Lymphocytic Leukemia and the Utility of Negative MYD88 L265P Testing in the Diagnosis.
    Balikov DA; Brown NA; Elner VM; Wubben TJ; Rao RC; Demirci H
    Ocul Oncol Pathol; 2024 Jun; 10(2):103-113. PubMed ID: 38882022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology.
    Shumilov E; Mazzeo P; Zinkernagel MS; Legros M; Porret N; Romagna L; Haase D; Lenz G; Novak U; Banz Y; Pabst T; Bacher U
    Curr Oncol; 2022 Jan; 29(2):766-776. PubMed ID: 35200564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Spontaneous Regression and Recurrence of Primary Vitreoretinal Lymphoma.
    Kim Y; Shin S; Lee ST; Lee CS
    Ocul Immunol Inflamm; 2022; 30(7-8):1980-1983. PubMed ID: 34255584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary vitreoretinal lymphoma: empowering our clinical suspicion.
    Takhar JS; Doan TA; Gonzales JA
    Curr Opin Ophthalmol; 2019 Nov; 30(6):491-499. PubMed ID: 31589186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PreservCyt Is an Optimal Fixative that Permits Cytologic and Molecular Analyses of Vitreoretinal Lymphoma Biopsies.
    Wang MM; Tan WJ; Lim TS; Chan ASY
    Ocul Immunol Inflamm; 2021 Apr; 29(3):430-439. PubMed ID: 31418635
    [No Abstract]   [Full Text] [Related]  

  • 19. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates.
    Bonzheim I; Giese S; Deuter C; Süsskind D; Zierhut M; Waizel M; Szurman P; Federmann B; Schmidt J; Quintanilla-Martinez L; Coupland SE; Bartz-Schmidt KU; Fend F
    Blood; 2015 Jul; 126(1):76-9. PubMed ID: 25900979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm.
    Shekhar R; Naseem S; Binota J; Varma N; Malhotra P
    Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):231-239. PubMed ID: 33217360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.